GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arrowhead Pharmaceuticals Inc (LTS:0HI3) » Definitions » Cyclically Adjusted Book per Share

Arrowhead Pharmaceuticals (LTS:0HI3) Cyclically Adjusted Book per Share : $3.28 (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Arrowhead Pharmaceuticals Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Arrowhead Pharmaceuticals's adjusted book value per share for the three months ended in Mar. 2024 was $3.897. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $3.28 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Arrowhead Pharmaceuticals's average Cyclically Adjusted Book Growth Rate was 4.50% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 16.40% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 17.10% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -8.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Arrowhead Pharmaceuticals was 64.00% per year. The lowest was -39.00% per year. And the median was 3.10% per year.

As of today (2024-06-24), Arrowhead Pharmaceuticals's current stock price is $24.91. Arrowhead Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $3.28. Arrowhead Pharmaceuticals's Cyclically Adjusted PB Ratio of today is 7.59.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Arrowhead Pharmaceuticals was 43.20. The lowest was 0.12. And the median was 8.38.


Arrowhead Pharmaceuticals Cyclically Adjusted Book per Share Historical Data

The historical data trend for Arrowhead Pharmaceuticals's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arrowhead Pharmaceuticals Cyclically Adjusted Book per Share Chart

Arrowhead Pharmaceuticals Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.63 2.39 2.42 2.87 3.30

Arrowhead Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.09 3.18 3.30 3.23 3.28

Competitive Comparison of Arrowhead Pharmaceuticals's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Arrowhead Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arrowhead Pharmaceuticals's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arrowhead Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Arrowhead Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.



Arrowhead Pharmaceuticals Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Arrowhead Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=3.897/131.7762*131.7762
=3.897

Current CPI (Mar. 2024) = 131.7762.

Arrowhead Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201406 3.522 100.560 4.615
201409 3.047 100.428 3.998
201412 2.673 99.070 3.555
201503 2.435 99.621 3.221
201506 2.207 100.684 2.889
201509 1.850 100.392 2.428
201512 1.558 99.792 2.057
201603 1.242 100.470 1.629
201606 0.993 101.688 1.287
201609 1.370 101.861 1.772
201612 1.314 101.863 1.700
201703 1.256 102.862 1.609
201706 1.205 103.349 1.536
201709 1.089 104.136 1.378
201712 0.944 104.011 1.196
201803 1.305 105.290 1.633
201806 1.165 106.317 1.444
201809 1.082 106.507 1.339
201812 1.858 105.998 2.310
201903 2.125 107.251 2.611
201906 2.376 108.070 2.897
201909 2.561 108.329 3.115
201912 4.946 108.420 6.011
202003 4.856 108.902 5.876
202006 4.823 108.767 5.843
202009 4.511 109.815 5.413
202012 4.404 109.897 5.281
202103 4.283 111.754 5.050
202106 4.192 114.631 4.819
202109 3.919 115.734 4.462
202112 3.555 117.630 3.983
202203 4.279 121.301 4.649
202206 4.291 125.017 4.523
202209 3.761 125.227 3.958
202212 3.552 125.222 3.738
202303 4.181 127.348 4.326
202306 3.406 128.729 3.487
202309 2.529 129.860 2.566
202312 1.492 129.419 1.519
202403 3.897 131.776 3.897

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Arrowhead Pharmaceuticals  (LTS:0HI3) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Arrowhead Pharmaceuticals's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=24.91/3.28
=7.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Arrowhead Pharmaceuticals was 43.20. The lowest was 0.12. And the median was 8.38.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Arrowhead Pharmaceuticals Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Arrowhead Pharmaceuticals's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Arrowhead Pharmaceuticals (LTS:0HI3) Business Description

Traded in Other Exchanges
Address
177 E. Colorado Boulevard, Suite 700, Pasadena, CA, USA, 91105
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

Arrowhead Pharmaceuticals (LTS:0HI3) Headlines

No Headlines